RGBD yields 57.85% · JNJ yields 2.14%● Live data
📍 RGBD pulled ahead of the other in Year 1
Combined, RGBD + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RGBD + JNJ for your $10,000?
Regional Brands Inc., through its subsidiaries, engages in the sale and distribution of windows, doors, and related hardware for use in commercial and residential buildings in the United States. It offers commercial windows, such as architectural aluminum, clad wood, fiberglass, composite, and diamond windows, as well as curtainwall and storefront products, interior fire rated glass and framing systems, and fiberglass reinforced entry door systems; and design development, budgeting, sample installation, energy surveys, prime contractor or subcontractor, bondable, complete submittal packages, installation, and other services. The company also distributes and installs commercial doors, frames, and hardware products, including wood doors, hollow metal doors and frames, locks, closers, exit devices, automatic operators, and other products. In addition, it supplies and installs specialty products comprising operable partitions, accordion doors, vertical folding walls, smoke and fire curtains, movable glass partition, and horizontal sliding fire doors, as well as repair services for its products. The company was formerly known as 4net Software, Inc. and changed its name to Regional Brands Inc. in May 2016. Regional Brands Inc. was founded in 1928 and is based in Mayfield Heights, Ohio.
Full RGBD Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.